Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

ENT Treatment Companies

ENT (Ear, Nose, and Throat) treatment companies offer a variety of medical devices, instruments, and solutions for the diagnosis and treatment of disorders related to the ear, nose, throat, and related structures. These companies cater to otolaryngologists, audiologists, and other healthcare professionals specializing in ENT care.

ENT Treatment Key Companies

 


Latest ENT Treatment Companies Update:

Sonova Holding AG


January 26, 2024: Announced the launch of the Phonak Audéo Paradise™ hearing aids with integrated biometrics sensing features for improved health monitoring and personalized hearing experiences.November 15, 2023: Received FDA approval for the EAS® Cochlear Implant System with features like AI-powered sound processing and integrated smart charger for improved hearing outcomes.


Medtronic plc


January 19, 2024: Launched the Stealth™ ENT Sinus System with enhanced navigation and visualization tools for improved accuracy and efficiency in sinus surgery.October 06, 2023: Acquired Intersect ENT, a developer of minimally invasive balloon sinuplasty devices, expanding its portfolio for treating chronic sinusitis.


Stryker Corporation


January 12, 2024: Unveiled the Sonoprobe® Elite ultrasonic aspirator with improved suction and tissue fragmentation capabilities for more efficient ENT procedures.September 21, 2023: Announced a collaboration with Google to develop AI-powered solutions for improving diagnosis and treatment of vocal cord disorders.


Johnson & Johnson (J&J)


December 22, 2023, Received FDA approval for the VERSA™ Transcutaneous Bone Anchored Hearing System, offering a new treatment option for conductive hearing loss patients.August 8, 2023, Expanded its ENT surgical device portfolio with the acquisition of Auris Surgical Robotics, a developer of robot-assisted ear surgery systems.


List of ENT Treatment Key companies in the market

  • Novartis AG

  • Pfizer Inc.

  • GlaxoSmithKline Pharmaceuticals

  • Teva Pharmaceuticals Industries Ltd.

  • Sonova Holding AG

  • Starkey Laboratories Inc.

  • Siemens Healthcare

  • Sonic Innovations Inc.

  • American Hearing Systems Inc.

  • Reddy’s Laboratories Ltd.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.